Experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial

Research output: Contribution to conferenceAbstract

Abstract

Abstract from the UK Pharmacy and Pharmacology Conference. Describes the experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial.
Original languageEnglish
Pages1433-1434
Number of pages2
DOIs
Publication statusPublished - Oct 2010

Fingerprint

Fenretinide
Clinical Trials, Phase I
Gelatin
Capsules
Pharmacology

Keywords

  • melt fill
  • fenretinide
  • hard gelatin capsules

Cite this

@conference{5541c1a1e85446c2ad708683557bf57d,
title = "Experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial",
abstract = "Abstract from the UK Pharmacy and Pharmacology Conference. Describes the experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial.",
keywords = "melt fill, fenretinide, hard gelatin capsules",
author = "Elliott, {M. A.} and Elke Schmidt and Ford, {S. J.} and Halbert, {G. W.}",
year = "2010",
month = "10",
doi = "10.1111/jphp.2010.62.issue-10/issuetoc",
language = "English",
pages = "1433--1434",

}

TY - CONF

T1 - Experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial

AU - Elliott, M. A.

AU - Schmidt, Elke

AU - Ford, S. J.

AU - Halbert, G. W.

PY - 2010/10

Y1 - 2010/10

N2 - Abstract from the UK Pharmacy and Pharmacology Conference. Describes the experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial.

AB - Abstract from the UK Pharmacy and Pharmacology Conference. Describes the experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial.

KW - melt fill

KW - fenretinide

KW - hard gelatin capsules

U2 - 10.1111/jphp.2010.62.issue-10/issuetoc

DO - 10.1111/jphp.2010.62.issue-10/issuetoc

M3 - Abstract

SP - 1433

EP - 1434

ER -